NCT00041106View on ClinicalTrials.gov

Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

July 31, 2007

Conditions
Metastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
Interventions
DRUG

gemcitabine hydrochloride

Given IV

DRUG

cisplatin

Given IV

DRUG

gefitinib

Given PO

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

60606

Cancer and Leukemia Group B, Chicago

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00041106 - Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer | Biotech Hunter | Biotech Hunter